Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sven N Reske

Showing results (41-50 of 89) with videos related to

Pageof 9
Sort By:
Cancer Gene Therapy|April 30, 2003
Triplex-forming oligodeoxynucleotides targeting survivin inhibit proliferation and induce apoptosis of human lung carcinoma cellsChangxian Shen, Andreas Buck, Bülent Polat, et al.
Bioorganic & Medicinal Chemistry Letters|July 28, 2009
Towards to hENT1-nucleoside transporter selective imaging agents. Synthesis and in vitro evaluation of the radiolabeled SAENTA analoguesBoris D Zlatopolskiy, Agnieszka Morgenroth, Elizaveta A Urusova, et al.
Radiology|December 21, 2006
Multiple Myeloma: Molecular Imaging with 11C-Methionine PET/CT--Initial ExperienceAnja Dankerl, Peter Liebisch, Gerhard Glatting, et al.
Archives of Orthopaedic and Trauma Surgery|July 29, 2009
Integrated FDG-PET-CT: its role in the assessment of bone and soft tissue tumorsMark Bischoff, Gisela Bischoff, Andreas Buck, et al.
Cancer Biotherapy & Radiopharmaceuticals|May 28, 2002
Myeloablative radioimmunotherapy with Re-188-anti-CD66-antibody for conditioning of high-risk leukemia patients prior to stem cell transplantation: biodistribution, biokinetics and immediate toxicitiesInga Buchmann, Donald Bunjes, Jörg Kotzerke, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 3, 2006
Imaging prostate cancer with 11C-choline PET/CTSven N Reske, Norbert M Blumstein, Bernd Neumaier, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 17, 2007
123I-ITdU-mediated nanoirradiation of DNA efficiently induces cell kill in HL60 leukemia cells and in doxorubicin-, beta-, or gamma-radiation-resistant cell linesSven N Reske, Sandra Deisenhofer, Gerhard Glatting, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 20, 2009
Synthesis and biologic study of IV-14, a new ribonucleoside radiotracer for tumor visualizationBoris D Zlatopolskiy, Agnieszka Morgenroth, Falk H-G Kunkel, et al.
World Journal of Urology|February 24, 2009
[(11)C]choline PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomyLudwig Rinnab, Joerg Simon, Richard E Hautmann, et al.
Nuclear Medicine and Biology|April 25, 2006
Synthesis and evaluation of a radiometal-labeled macrocyclic chelator-derivatised thymidine analogMichaela Schmid, Bernd Neumaier, Andreas T J Vogg, et al.
Pageof 9

Showing results (41-50 of 89) with videos related to

Sort By:
Pageof 9
Cancer Gene Therapy|April 30, 2003
Triplex-forming oligodeoxynucleotides targeting survivin inhibit proliferation and induce apoptosis of human lung carcinoma cellsChangxian Shen, Andreas Buck, Bülent Polat, et al.
Bioorganic & Medicinal Chemistry Letters|July 28, 2009
Towards to hENT1-nucleoside transporter selective imaging agents. Synthesis and in vitro evaluation of the radiolabeled SAENTA analoguesBoris D Zlatopolskiy, Agnieszka Morgenroth, Elizaveta A Urusova, et al.
Radiology|December 21, 2006
Multiple Myeloma: Molecular Imaging with 11C-Methionine PET/CT--Initial ExperienceAnja Dankerl, Peter Liebisch, Gerhard Glatting, et al.
Archives of Orthopaedic and Trauma Surgery|July 29, 2009
Integrated FDG-PET-CT: its role in the assessment of bone and soft tissue tumorsMark Bischoff, Gisela Bischoff, Andreas Buck, et al.
Cancer Biotherapy & Radiopharmaceuticals|May 28, 2002
Myeloablative radioimmunotherapy with Re-188-anti-CD66-antibody for conditioning of high-risk leukemia patients prior to stem cell transplantation: biodistribution, biokinetics and immediate toxicitiesInga Buchmann, Donald Bunjes, Jörg Kotzerke, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 3, 2006
Imaging prostate cancer with 11C-choline PET/CTSven N Reske, Norbert M Blumstein, Bernd Neumaier, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 17, 2007
123I-ITdU-mediated nanoirradiation of DNA efficiently induces cell kill in HL60 leukemia cells and in doxorubicin-, beta-, or gamma-radiation-resistant cell linesSven N Reske, Sandra Deisenhofer, Gerhard Glatting, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 20, 2009
Synthesis and biologic study of IV-14, a new ribonucleoside radiotracer for tumor visualizationBoris D Zlatopolskiy, Agnieszka Morgenroth, Falk H-G Kunkel, et al.
World Journal of Urology|February 24, 2009
[(11)C]choline PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomyLudwig Rinnab, Joerg Simon, Richard E Hautmann, et al.
Nuclear Medicine and Biology|April 25, 2006
Synthesis and evaluation of a radiometal-labeled macrocyclic chelator-derivatised thymidine analogMichaela Schmid, Bernd Neumaier, Andreas T J Vogg, et al.
Pageof 9